Literature DB >> 12112115

A novel D104G mutation in the adenine nucleotide translocator 1 gene in autosomal dominant progressive external ophthalmoplegia patients with mitochondrial DNA with multiple deletions.

Hirofumi Komaki1, Toshiyuki Fukazawa, Hideki Houzen, Kazuto Yoshida, Ikuya Nonaka, Yu-ichi Goto.   

Abstract

Autosomal dominant progressive external ophthalmoplegia is a mitochondrial disorder characterized by multiple large deletions of mitochondrial DNA. A recent study showed pathogenic heterozygous missense mutations in the heart/skeletal muscle isoform of the adenine nucleotide translocator 1 gene in autosomal dominant progressive external ophthalmoplegia patients. In one Japanese autosomal dominant progressive external ophthalmoplegia family, we found a novel A-to-G heterozygous mutation at nucleotide 311 of the adenine nucleotide translocator 1 gene, which segregated with affected individuals and could not be detected in the genomic DNA sequence of 120 normal controls. This mutation converted a highly conserved aspartic acid into a glycine at codon 104. Polymerase chain reaction analysis of single muscle fibers showed the presence of one type of deletion in each fiber, suggesting clonal expansion of mitochondrial DNA with deletions. These findings support the pathogenesis of the adenine nucleotide translocator 1 gene mutation in human disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12112115     DOI: 10.1002/ana.10172

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  22 in total

Review 1.  Insights into the mitochondrial signaling pathway: what lessons for chemotherapy?

Authors:  Catherine Brenner; Morgane Le Bras; Guido Kroemer
Journal:  J Clin Immunol       Date:  2003-03       Impact factor: 8.317

2.  Dominant membrane uncoupling by mutant adenine nucleotide translocase in mitochondrial diseases.

Authors:  Xiaowen Wang; Kelly Salinas; Xiaoming Zuo; Blanka Kucejova; Xin Jie Chen
Journal:  Hum Mol Genet       Date:  2008-09-22       Impact factor: 6.150

Review 3.  Consequences of inner mitochondrial membrane protein misfolding.

Authors:  Liam P Coyne; Xin Jie Chen
Journal:  Mitochondrion       Date:  2019-06-10       Impact factor: 4.160

Review 4.  20,000 picometers under the OMM: diving into the vastness of mitochondrial metabolite transport.

Authors:  Corey N Cunningham; Jared Rutter
Journal:  EMBO Rep       Date:  2020-04-23       Impact factor: 8.807

5.  Two Novel Mutations in the SLC25A4 Gene in a Patient with Mitochondrial Myopathy.

Authors:  I M L W Körver-Keularts; M de Visser; H D Bakker; R J A Wanders; F Vansenne; H R Scholte; L Dorland; G A F Nicolaes; L M J Spaapen; H J M Smeets; A T M Hendrickx; B J C van den Bosch
Journal:  JIMD Rep       Date:  2015-03-03

6.  adPEO mutations in ANT1 impair ADP-ATP translocation in muscle mitochondria.

Authors:  Hibiki Kawamata; Valeria Tiranti; Jordi Magrané; Christos Chinopoulos; Giovanni Manfredi
Journal:  Hum Mol Genet       Date:  2011-05-17       Impact factor: 6.150

Review 7.  Biology of mitochondria in neurodegenerative diseases.

Authors:  Lee J Martin
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

8.  The yeast Aac2 protein exists in physical association with the cytochrome bc1-COX supercomplex and the TIM23 machinery.

Authors:  Mary K Dienhart; Rosemary A Stuart
Journal:  Mol Biol Cell       Date:  2008-07-09       Impact factor: 4.138

9.  Suppression of mitochondrial DNA instability of autosomal dominant forms of progressive external ophthalmoplegia-associated ANT1 mutations in Podospora anserina.

Authors:  Riyad El-Khoury; Annie Sainsard-Chanet
Journal:  Genetics       Date:  2009-08-17       Impact factor: 4.562

Review 10.  Phenotypic spectrum of SLC25A4 mutations.

Authors:  Josef Finsterer; Sinda Zarrouk-Mahjoub
Journal:  Biomed Rep       Date:  2018-06-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.